Newsfeed : Scripps Research Institute Gets $77M to Develop HIV Vaccine

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Newsfeed » July 2012

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

July 13, 2012

Scripps Research Institute Gets $77M to Develop HIV Vaccine

The Scripps Research Institute (SRI) was awarded $77 million over seven years from the National Institute of Allergy and Infectious Diseases (NIAID) to focus on developing an HIV vaccine, according to an SRI statement. NIAID, which is part of the National Institutes of Health, offered two Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) grants to support a coordinated, multidisciplinary team of researchers focused on multipronged approaches to accelerate HIV vaccine development. SRI, a large, independent, nonprofit biomedical research organization, will investigate immune responses that may be able to prevent HIV infection or suppress it in people with the virus. Specifically, scientists will study antibodies and B cells (the cells that produce antibodies) and other components of the immune system. The other CHAVI-ID grant was awarded to Duke University in Durham, North Carolina.

To read the SRI statement, click here.


Search: Durham, North Carolina, Duke University, Scripps Research Institute, National Institute of Allergy and Infectious Diseases, National Institutes of Health, HIV/AIDS Vaccine Immunology and Immunogen Discovery


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    dlw8585
    Fort Lauderdale
    Florida


    mtaj0818
    Washington
    DC


    OahuAJ
    Glendora
    California


    jacob2608
    Panama City Beach
    Florida
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Are you a regular coffee drinker?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.